Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Simonelli

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
AIDS (London, England)|February 10, 1998
Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemiaC Simonelli, S Zanussi, M Comar, et al.
The Journal of Infectious Diseases|July 1, 1996
Treatment of human immunodeficiency virus infection with hydroxyurea: virologic and clinical evaluationM Giacca, S Zanussi, M Comar, et al.
Journal of Clinical Immunology|October 27, 1999
Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2P De Paoli, S Zanussi, L Caggiari, et al.
International Journal of Clinical & Laboratory Research|January 1, 1991
Cytokine production by allergen (Der pI)-specific CD4+ T cell clones derived from a patient with severe atopic diseaseP Parronchi, R Manetti, C Simonelli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 16, 2009
Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppressionN Binkley, S L Silverman, C Simonelli, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2018
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusionsG Ianiro, L Masucci, G Quaranta, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1996
Hydroxyurea treatment in HIV-infected patientsC Simonelli, G Nasti, E Vaccher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patientsM Berretta, C Simonelli, A Lleshi, et al.
Clinical and Experimental Immunology|April 12, 2000
Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patientsL Caggiari, S Zanussi, M T Bortolin, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|May 6, 2008
A novel DXA-based hip failure index captures hip fragility independent of BMDH Sievänen, L S Weynand, W K Wacker, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
AIDS (London, England)|February 10, 1998
Interleukin-2 in combination with zidovudine and didanosine is able to maintain high levels of CD4 cells and undetectable HIV viraemiaC Simonelli, S Zanussi, M Comar, et al.
The Journal of Infectious Diseases|July 1, 1996
Treatment of human immunodeficiency virus infection with hydroxyurea: virologic and clinical evaluationM Giacca, S Zanussi, M Comar, et al.
Journal of Clinical Immunology|October 27, 1999
Kinetics of lymphokine production in HIV+ patients treated with highly active antiretroviral therapy and interleukin 2P De Paoli, S Zanussi, L Caggiari, et al.
International Journal of Clinical & Laboratory Research|January 1, 1991
Cytokine production by allergen (Der pI)-specific CD4+ T cell clones derived from a patient with severe atopic diseaseP Parronchi, R Manetti, C Simonelli, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|January 16, 2009
Monthly ibandronate suppresses serum CTX-I within 3 days and maintains a monthly fluctuating pattern of suppressionN Binkley, S L Silverman, C Simonelli, et al.
Alimentary Pharmacology & Therapeutics|June 1, 2018
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusionsG Ianiro, L Masucci, G Quaranta, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|December 15, 1996
Hydroxyurea treatment in HIV-infected patientsC Simonelli, G Nasti, E Vaccher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 18, 2005
Oxaliplatin-based chemotherapy in association with highly active antiretroviral therapy in metastatic colorectal cancer HIV-infected patientsM Berretta, C Simonelli, A Lleshi, et al.
Clinical and Experimental Immunology|April 12, 2000
Effects of therapy with highly active anti-retroviral therapy (HAART) and IL-2 on CD4+ and CD8+ lymphocyte apoptosis in HIV+ patientsL Caggiari, S Zanussi, M T Bortolin, et al.
Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry|May 6, 2008
A novel DXA-based hip failure index captures hip fragility independent of BMDH Sievänen, L S Weynand, W K Wacker, et al.
Pageof 9